支持非洲社区提高发育障碍儿童及其照护者心理韧性及心理健康:基于世界卫生组织照护者技能培训项目的SPARK试验——整群随机临床对照试验研究方案
该方案计划在肯尼亚和埃塞俄比亚城乡四站点开展双臂多站点混合1型有效性实施整群随机对照优效性试验,比较WHO照护者技能培训(CST)干预与等待名单强化常规照护,共招募544对看护者-儿童 dyad,主要结局为终点时儿童行为量表和照护者生活质量量表。
要点
- 拟招募544对看护者-儿童 dyad,均匀分配至两臂及两国。
- 干预含3次个体化家访和9次小组课程,由受训非专业引导员实施。
- 共同主要结局为终点时儿童行为量表和照护者生活质量量表。
核心结论
- 研究结果将提供非专业引导员在资源匮乏环境下实施干预的有效性及资源影响、成本和后果的证据。
- 结果将指导未来研究、干预和政策,以支持资源匮乏的多数世界背景下的发育障碍儿童及其家庭。
研究设计与样本
- 2臂多站点混合1型有效性实施整群随机对照优效性试验,在肯尼亚和埃塞俄比亚的城乡四站点开展。
- 基线评估(T0)完成后,由7至10对看护者-儿童 dyad 组成的整群被随机分配至WHO CST干预臂或等待名单强化常规照护对照臂。
- 计划招募544对儿童-看护者 dyad,均匀分配至两臂和两国。
- 终点评估(T1)在随机化后18±2周进行,随访评估(T2)在随机化后44±2周进行。
- 干预包括3次个体化家访和9次小组课程,由受训非专业引导员实施;对照臂参与者在完成随访评估后接受干预。
主要发现
- 共同主要结局为终点时评估的以儿童为中心的儿童行为量表(评估情绪和行为问题)和以照护者为中心的儿科生活质量量表(评估照护者生活质量)。
- 次要结局包括随访时两个共同主要结局及终点时十项额外结局指标,评估污名体验、抑郁症状、家庭食物不安全、儿童管教策略与信念、CST知识与技能胜任力、照护者与儿童生活质量、社会支持以及儿童沟通方式与功能。
- 定量随访评估完成后,将采用混合方法评估实施过程及干预的可接受性、可行性和潜在可持续性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most children with developmental disabilities (DD) live in low- and middle-income countries, but access to services is limited, impacting their ability to thrive. Pilot study findings of the World Health Organization's Caregiver Skills Training (WHO CST) intervention, which equips caregivers with strategies to facilitate learning and adaptive behaviours in children with DD, are promising but evidence from an appropriately powered trial delivered by non-specialist facilitators is lacking. This study will investigate the effectiveness and the resource impacts and costs and consequences of the WHO CST intervention in four sites in rural and urban Kenya and Ethiopia. METHODS: This is a 2-arm multi-site hybrid type-1 effectiveness implementation cluster randomised controlled superiority trial. After baseline assessments (T0) are completed by participants in clusters comprising 7 to 10 caregiver-child dyads, the clusters will be randomised to either the WHO CST intervention arm or a waitlist enhanced care as usual control arm. Further assessments will be completed at endpoint (T1, 18 ± 2 weeks after randomisation) and follow-up (T2, 44 ± 2 weeks after randomisation). The intervention comprises three individualised home visits and nine group sessions with trained non-specialist facilitators. Participants in the control arm will receive the intervention after completing follow-up assessments. We aim to recruit 544 child-caregiver dyads, evenly distributed across the two arms and countries. The co-primary outcomes are the child-focused Child Behavior Checklist (assessing emotional and behavioural problems) and the caregiver-focused Pediatric Quality of Life Inventory (assessing caregiver quality of life), both assessed at endpoint. Secondary outcome measures comprise the two co-primary outcomes at follow-up and ten additional outcome measures at endpoint, assessing stigma-based experiences, depressive symptoms, household food insecurity, child disciplinary strategies and beliefs, CST knowledge and skill competencies, caregiver and child quality of life, social support, and children's communication modes and functions. After quantitative follow-up assessments are completed, a mixed-methods evaluation approach will be used to investigate implementation processes and acceptability, feasibility, and potential sustainability of the intervention. DISCUSSION: The study's findings will provide evidence of the effectiveness and resource impacts and costs and consequences of a non-specialist-delivered intervention in under-resourced contexts in one low-income and one middle-income country in East Africa. Findings will inform future research, intervention, and policy efforts to support children with DD and their families in under-resourced majority world contexts. TRIAL REGISTRATION: Pan African Clinical Trial Registry PACTR202310908063134. Registered on October 16, 2023.
引用
- Washington-Nortey M, Angwenyi V, Demissie M, et al. Supporting African communities to increase resilience and mental health of kids with developmental disabilities and their caregivers using the World Health Organization's Caregiver Skills Training Programme (SPARK trial): study protocol for a cluster randomised clinical controlled trial. Trials. 2024. PMID: 39449002. doi:10.1186/s13063-024-08488-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。